Legend Biotech Corporation (LEGN)
USD 31.25
(-4.96%)
USD 31.25
(-4.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 589.93 Million USD | 0.56% |
| 2022 | 586.65 Million USD | -9.35% |
| 2021 | 647.16 Million USD | 46.83% |
| 2020 | 440.75 Million USD | 7.35% |
| 2019 | 410.58 Million USD | -2.33% |
| 2018 | 420.39 Million USD | 85.59% |
| 2017 | 226.52 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 604.38 Million USD | 2.45% |
| 2024 Q2 | 632.6 Million USD | 5.76% |
| 2023 Q1 | 556.2 Million USD | -5.19% |
| 2023 Q4 | 589.93 Million USD | 18.06% |
| 2023 Q2 | 523.62 Million USD | -5.86% |
| 2023 FY | 589.93 Million USD | 0.56% |
| 2023 Q3 | 499.69 Million USD | -4.57% |
| 2022 Q1 | 601.95 Million USD | -6.99% |
| 2022 Q4 | 586.65 Million USD | 0.0% |
| 2022 Q3 | 586.65 Million USD | 27.5% |
| 2022 FY | 586.65 Million USD | -9.35% |
| 2022 Q2 | 460.11 Million USD | -23.56% |
| 2021 Q1 | 408.8 Million USD | -7.25% |
| 2021 FY | 647.16 Million USD | 46.83% |
| 2021 Q4 | 647.16 Million USD | 10.08% |
| 2021 Q3 | 587.89 Million USD | 9.85% |
| 2021 Q2 | 535.2 Million USD | 30.92% |
| 2020 Q4 | 440.75 Million USD | 17.93% |
| 2020 FY | 440.75 Million USD | 7.35% |
| 2020 Q2 | 371.86 Million USD | -2.35% |
| 2020 Q1 | 380.81 Million USD | -7.25% |
| 2020 Q3 | 373.73 Million USD | 0.5% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 410.58 Million USD | -2.33% |
| 2019 Q4 | 410.58 Million USD | 0.0% |
| 2018 FY | 420.39 Million USD | 85.59% |
| 2017 FY | 226.52 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -75.692% |
| Alkermes plc | 933.53 Million USD | 36.807% |
| Agenus Inc. | 462.29 Million USD | -27.61% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 85.436% |
| Aptorum Group Limited | 5.25 Million USD | -11122.416% |
| Ardelyx, Inc. | 130.76 Million USD | -351.147% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -23.316% |
| Bicycle Therapeutics plc | 224.41 Million USD | -162.879% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -353.063% |
| ChromaDex Corporation | 26.5 Million USD | -2125.49% |
| Chimerix, Inc. | 19.74 Million USD | -2887.759% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1577.036% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -712.949% |
| CRISPR Therapeutics AG | 346.76 Million USD | -70.123% |
| Precision BioSciences, Inc. | 140.92 Million USD | -318.63% |
| Dyadic International, Inc. | 2.34 Million USD | -25103.8% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3527.455% |
| Fortress Biotech, Inc. | 165.93 Million USD | -255.512% |
| Lantern Pharma Inc. | 2.73 Million USD | -21432.901% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -725.312% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -16618.021% |
| Incyte Corporation | 1.59 Billion USD | 62.95% |
| IO Biotech, Inc. | 17.55 Million USD | -3260.293% |
| Jaguar Health, Inc. | 45.86 Million USD | -1186.21% |
| Novavax, Inc. | 2.57 Billion USD | 77.066% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1536.067% |
| Opthea Limited | 264.6 Million USD | -122.952% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -351.34% |
| ContextLogic Inc. | 206 Million USD | -186.375% |
| MiMedx Group, Inc. | 96.33 Million USD | -512.408% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1128.464% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -16617.254% |
| NextCure, Inc. | 14.99 Million USD | -3833.673% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -14495.077% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -8735.3% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1162.186% |
| Vaxcyte, Inc. | 167.44 Million USD | -252.306% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1673.747% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -150.807% |
| Pharming Group N.V. | 244.07 Million USD | -141.704% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4848.272% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -361.639% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8828.532% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8828.532% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -615.651% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -8780.521% |
| Acelyrin, Inc. | 86.35 Million USD | -583.164% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -45305.972% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4002.74% |
| Summit Therapeutics Inc. | 125.25 Million USD | -370.978% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6123.578% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1022.164% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -757.748% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -289.364% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -30060.174% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -44071.077% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -160.075% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6197.993% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -159.374% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -19.297% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5305.287% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2044.353% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4773.587% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -21.235% |
| Immix Biopharma, Inc. | 3.72 Million USD | -15750.817% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1460.174% |
| MEI Pharma, Inc. | 8.35 Million USD | -6960.838% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1933.2% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -69.726% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -304.427% |
| Fortress Biotech, Inc. | 165.93 Million USD | -255.512% |
| Precigen, Inc. | 41.64 Million USD | -1316.61% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1081.52% |
| AlloVir, Inc. | 45.01 Million USD | -1210.525% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -352.621% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -328.108% |
| ImmuCell Corporation | 18.81 Million USD | -3035.436% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1990.034% |
| Onconetix, Inc. | 23.18 Million USD | -2444.911% |
| PureTech Health plc | 125.58 Million USD | -369.755% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6491.43% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1620.824% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -24028.139% |
| Seer, Inc. | 39.36 Million USD | -1398.623% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -854.059% |
| Innoviva, Inc. | 568.55 Million USD | -3.761% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2066.641% |
| ESSA Pharma Inc. | 3.49 Million USD | -16778.999% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8447.185% |
| GT Biopharma, Inc. | 6.63 Million USD | -8793.909% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -123.13% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -116.659% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -602.084% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5935.738% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2071.346% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -18188.113% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -699.725% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3631.698% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5243.748% |
| Soligenix, Inc. | 7.27 Million USD | -8009.152% |
| Century Therapeutics, Inc. | 175.94 Million USD | -235.302% |
| Kura Oncology, Inc. | 51.66 Million USD | -1041.909% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -386.414% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -14173.724% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -8819.654% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -133.546% |
| Autolus Therapeutics plc | 263.9 Million USD | -123.538% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5528.058% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -563.883% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1157.88% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -67.188% |
| GRI Bio, Inc. | 2.69 Million USD | -21773.674% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -72768.568% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1797.44% |
| IGM Biosciences, Inc. | 220.17 Million USD | -167.936% |
| INmune Bio, Inc. | 18.86 Million USD | -3027.627% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -130.012% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2114.313% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21601.431% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -17884.304% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -909.209% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -513.497% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -122.839% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 28.322% |
| Verastem, Inc. | 71.18 Million USD | -728.732% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1099.636% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1429.195% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1105.618% |
| Histogen Inc. | 5.69 Million USD | -10255.152% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -13351.576% |
| Surrozen, Inc. | 8.14 Million USD | -7142.885% |
| Organovo Holdings, Inc. | 2.74 Million USD | -21367.722% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -187861.753% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -949.145% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3472.753% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1054.4% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -71244.883% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -365.522% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5355.478% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -290.972% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -22525.813% |
| Apollomics, Inc. | 14.15 Million USD | -4068.254% |
| Amarin Corporation plc | 279.58 Million USD | -111.002% |
| Mesoblast Limited | 188.79 Million USD | -212.468% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4069.727% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -226.312% |
| Synaptogenix, Inc. | 5.52 Million USD | -10568.891% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -8773.842% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -246.799% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6794.001% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -33468.644% |
| Exelixis, Inc. | 678.44 Million USD | 13.046% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2374.344% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -259.614% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 0.72% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5423.612% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -36234.515% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1415.485% |
| Gritstone bio, Inc. | 125.91 Million USD | -368.502% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3919.712% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -11493.166% |
| Avid Bioservices, Inc. | 275.66 Million USD | -114.001% |
| Insmed Incorporated | 1.66 Billion USD | 64.5% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -7567.418% |
| MediWound Ltd. | 27.18 Million USD | -2069.908% |
| OmniAb, Inc. | 87.4 Million USD | -574.981% |
| Alector, Inc. | 487.66 Million USD | -20.97% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -46.22% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3101.807% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1437.365% |
| Zai Lab Limited | 240.17 Million USD | -145.624% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 6.368% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1918.452% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -520.479% |
| Immunic, Inc. | 25.36 Million USD | -2225.501% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -752.061% |
| Veracyte, Inc. | 93.71 Million USD | -529.47% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -22445.156% |
| FibroGen, Inc. | 585.72 Million USD | -0.718% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3293.735% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -90231.447% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -10331.215% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 92.295% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7096.06% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -602.117% |
| TG Therapeutics, Inc. | 169.08 Million USD | -248.897% |
| Galecto, Inc. | 5.89 Million USD | -9905.648% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -7021.354% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 77.47% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1946.815% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4574.218% |
| XBiotech Inc. | 8.39 Million USD | -6925.521% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3919.712% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1009.314% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -62.469% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2094.365% |
| Theravance Biopharma, Inc. | 169 Million USD | -249.065% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 51.47% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -17.886% |
| Vaxxinity, Inc. | 30.94 Million USD | -1806.454% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 39.338% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -9681.504% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 20.839% |
| NexImmune, Inc. | 5.08 Million USD | -11503.188% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -158742.9% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -19085.761% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.699% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -11346.053% |
| Scopus BioPharma Inc. | 7.45 Million USD | -7813.854% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2143.603% |
| Ainos, Inc. | 7.39 Million USD | -7878.296% |
| Pluri Inc. | 34.11 Million USD | -1629.4% |
| Prothena Corporation plc | 135.01 Million USD | -336.932% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -142.668% |
| Celularity Inc. | 102.92 Million USD | -473.146% |
| Rallybio Corporation | 9.43 Million USD | -6151.939% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2313.307% |
| MeiraGTx Holdings plc | 319.99 Million USD | -84.359% |
| Omeros Corporation | 403.25 Million USD | -46.294% |
| Humacyte, Inc. | 114.67 Million USD | -414.43% |
| Immunocore Holdings plc | 228.15 Million USD | -158.563% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -12001.19% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -668.743% |
| Blueprint Medicines Corporation | 918.64 Million USD | 35.782% |
| CalciMedica, Inc. | 4.02 Million USD | -14545.804% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3280.317% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -282.718% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -587.431% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -112.364% |
| Pulmatrix, Inc. | 15.96 Million USD | -3595.627% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3640.145% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2297.517% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -135.213% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1061.605% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 51.271% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1756.127% |
| Nutriband Inc. | 1.07 Million USD | -54578.155% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5448.133% |
| Vor Biopharma Inc. | 59.1 Million USD | -898.127% |
| Roivant Sciences Ltd. | 773.95 Million USD | 23.777% |
| Evogene Ltd. | 17.99 Million USD | -3179.227% |
| ProKidney Corp. | 29.21 Million USD | -1919.212% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -719.59% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -83580.458% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 68.769% |
| CorMedix Inc. | 11.91 Million USD | -4850.129% |
| BioLineRx Ltd. | 50.7 Million USD | -1063.53% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -294.712% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -567.036% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1099.978% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1793.706% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3184.339% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -373.325% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -10333.905% |
| MediciNova, Inc. | 3.89 Million USD | -15059.321% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3127.381% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -39117.984% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16660.027% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -48.501% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1822.232% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 78.325% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3595.859% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1790.75% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -905.271% |
| Absci Corporation | 58.3 Million USD | -911.823% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2997.086% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1739.976% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -699.476% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -574.34% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1646.914% |
| Allakos Inc. | 74.79 Million USD | -688.754% |
| Imunon, Inc. | 8.53 Million USD | -6815.633% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2521.808% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -413.825% |
| BioAtla, Inc. | 48.98 Million USD | -1104.289% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5423.612% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -21128.248% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -351.696% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4050.074% |
| XOMA Corporation | 145.58 Million USD | -305.229% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1652.363% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -757.972% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1767.054% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -854.229% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1211.983% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1118.819% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -20455.157% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7131.328% |
| Akari Therapeutics, Plc | 4.58 Million USD | -12769.394% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3226.728% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 64.235% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -145956.28% |
| UroGen Pharma Ltd. | 243.52 Million USD | -142.249% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -83.73% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -21262.325% |
| Orgenesis Inc. | 35.53 Million USD | -1560.146% |
| Entera Bio Ltd. | 1.37 Million USD | -42679.768% |
| GH Research PLC | 6.7 Million USD | -8703.656% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -8575.485% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3033.608% |
| Xencor, Inc. | 283.55 Million USD | -108.046% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -19658.782% |
| Replimune Group, Inc. | 113.21 Million USD | -421.078% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -15601.713% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -469.818% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -145956.28% |
| Portage Biotech Inc. | 4.45 Million USD | -13156.921% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -39117.984% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2459.362% |
| OncoCyte Corporation | 49.29 Million USD | -1096.667% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -14160.595% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -73874.274% |
| Purple Biotech Ltd. | 10 Million USD | -5796.382% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10095.869% |
| scPharmaceuticals Inc. | 57.26 Million USD | -930.253% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4662.125% |
| HilleVax, Inc. | 78.9 Million USD | -647.612% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -11581.842% |
| Tharimmune, Inc. | 1.81 Million USD | -32402.372% |
| Genprex, Inc. | 3.25 Million USD | -18028.313% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2075.349% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11166.864% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -286275.243% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -164433.898% |
| OKYO Pharma Limited | 7.42 Million USD | -7849.673% |
| Savara Inc. | 37.19 Million USD | -1486.183% |
| Curis, Inc. | 57.61 Million USD | -923.976% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2140.548% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1404.939% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -40754.086% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2733.628% |
| BeiGene, Ltd. | 2.23 Billion USD | 73.59% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2670.965% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -124.825% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2673.023% |
| Erasca, Inc. | 78.61 Million USD | -650.446% |
| bluebird bio, Inc. | 424.62 Million USD | -38.931% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89931.469% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 68.788% |
| DBV Technologies S.A. | 42.8 Million USD | -1278.348% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89931.469% |
| Moderna, Inc. | 4.57 Billion USD | 87.097% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8333.638% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -35523.973% |
| Molecular Templates, Inc. | 31.17 Million USD | -1792.57% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3355.964% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -0.311% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -373.823% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2050.137% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1518.206% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -960.363% |
| MacroGenics, Inc. | 154.2 Million USD | -282.559% |
| RenovoRx, Inc. | 4.46 Million USD | -13109.427% |
| Adicet Bio, Inc. | 37.12 Million USD | -1489.259% |
| Prime Medicine, Inc. | 60.78 Million USD | -870.604% |
| Aditxt, Inc. | 28.53 Million USD | -1967.651% |
| Adagene Inc. | 45.16 Million USD | -1206.047% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -326369.14% |
| Quantum-Si incorporated | 26.63 Million USD | -2115.212% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 15.43% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -19290.14% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -413.159% |
| SciSparc Ltd. | 1.59 Million USD | -36886.395% |
| Vericel Corporation | 127.7 Million USD | -361.95% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10500.975% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -591.127% |
| Generation Bio Co. | 171.63 Million USD | -243.724% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5007.645% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1310.277% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -133.454% |
| Invivyd, Inc. | 51.71 Million USD | -1040.783% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -541.392% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -8968.566% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -681.41% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -57679.922% |
| 2seventy bio, Inc. | 310.12 Million USD | -90.224% |
| ADMA Biologics, Inc. | 193.97 Million USD | -204.127% |
| Clene Inc. | 38.95 Million USD | -1414.552% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1532.677% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -129.567% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16660.027% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -210.062% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4743.591% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -197.462% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4737.578% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1126.192% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1016.43% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -59.504% |
| Evaxion Biotech A/S | 17.61 Million USD | -3248.566% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -266.58% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -285.109% |
| Trevena, Inc. | 48.26 Million USD | -1122.355% |
| Surrozen, Inc. | 8.14 Million USD | -7142.885% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2631.804% |
| Cingulate Inc. | 10.36 Million USD | -5593.859% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -21352.109% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1481.929% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -16348.619% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4386.183% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -85.981% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2274.071% |
| Clearmind Medicine Inc. | 3.61 Million USD | -16241.598% |
| Kronos Bio, Inc. | 54.2 Million USD | -988.417% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1154.029% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2492.003% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2839.231% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2501.522% |
| ImmunityBio, Inc. | 1.09 Billion USD | 45.897% |
| Korro Bio, Inc. | 51.75 Million USD | -1039.923% |
| Kineta, Inc. | 7.22 Million USD | -8068.554% |
| BioVie Inc. | 9.7 Million USD | -5980.448% |
| Codexis, Inc. | 49.94 Million USD | -1081.142% |
| Celularity Inc. | 102.92 Million USD | -473.146% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -512.937% |
| Celcuity Inc. | 51.45 Million USD | -1046.612% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -170798.973% |
| Cibus, Inc. | 206.11 Million USD | -186.213% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1288.895% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2139.77% |
| IN8bio, Inc. | 8.77 Million USD | -6625.182% |
| Kodiak Sciences Inc. | 213.59 Million USD | -176.197% |
| Annexon, Inc. | 47.11 Million USD | -1152.033% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -558.841% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -512.141% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4209.541% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 77.34% |
| Eyenovia, Inc. | 19.78 Million USD | -2882.43% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -233.134% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7580.419% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2347.956% |
| Arcellx, Inc. | 339.75 Million USD | -73.636% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4858.253% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -140.259% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6068.911% |
| Moolec Science SA | 13.94 Million USD | -4130.319% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1267.105% |
| Geron Corporation | 146.12 Million USD | -303.713% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1067.444% |
| Royalty Pharma plc | 6.29 Billion USD | 90.632% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1383.138% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -200280.767% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -23878.268% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -211.876% |
| Humacyte, Inc. | 114.67 Million USD | -414.43% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1930.68% |
| 89bio, Inc. | 59.96 Million USD | -883.828% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2129.275% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -49225.502% |
| Genelux Corporation | 8.42 Million USD | -6906.33% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -8504.624% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -332.759% |
| Notable Labs, Ltd. | 4.42 Million USD | -13225.796% |
| Liquidia Corporation | 73.13 Million USD | -706.603% |
| Mustang Bio, Inc. | 17.61 Million USD | -3248.277% |
| Immunovant, Inc. | 48.95 Million USD | -1105.052% |
| Quantum-Si incorporated | 26.63 Million USD | -2115.212% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1436.964% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -18911.698% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -698.707% |
| Acasti Pharma Inc. | 11.55 Million USD | -5004.551% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2509.43% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21601.431% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1499.732% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -43186.969% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -9577.379% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2275.41% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2444.57% |
| PepGen Inc. | 34.63 Million USD | -1603.482% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4757.815% |
| United Therapeutics Corporation | 1.18 Billion USD | 50.099% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8346.922% |
| Solid Biosciences Inc. | 38.45 Million USD | -1433.967% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6794.001% |
| Immuneering Corporation | 12 Million USD | -4812.688% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -187861.753% |
| Silo Pharma, Inc. | 1.56 Million USD | -37492.83% |
| Belite Bio, Inc | 4.21 Million USD | -13909.333% |
| XOMA Corporation | 145.58 Million USD | -305.229% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -24197.076% |
| Bionomics Limited | 10.15 Million USD | -5707.158% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2645.023% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2474.665% |
| uniQure N.V. | 624.01 Million USD | 5.462% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4055.921% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -326369.14% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -246.644% |
| Forte Biosciences, Inc. | 3.66 Million USD | -15992.008% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -226289.672% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -8643.634% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7580.419% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3293.735% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5482.258% |
| Altimmune, Inc. | 16.54 Million USD | -3466.489% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 4.496% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2474.665% |
| Compugen Ltd. | 55.77 Million USD | -957.701% |
| Peak Bio, Inc. | 20.75 Million USD | -2742.59% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -434.055% |
| Benitec Biopharma Inc. | 4.96 Million USD | -11789.017% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -273.747% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -684.757% |
| Zura Bio Limited | 21.29 Million USD | -2670.679% |
| PolyPid Ltd. | 17.46 Million USD | -3277.221% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -424.856% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -684.757% |
| Instil Bio, Inc. | 99.8 Million USD | -491.109% |
| argenx SE | 444.95 Million USD | -32.584% |
| Immunome, Inc. | 28.65 Million USD | -1958.528% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -6976.083% |
| Verona Pharma plc | 58.84 Million USD | -902.588% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3976.093% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3870.207% |
| CervoMed Inc. | 2.59 Million USD | -22626.907% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -12003.673% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4532.012% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5499.744% |
| Moolec Science SA | 13.94 Million USD | -4130.319% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -25073.117% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -961.12% |
| AnaptysBio, Inc. | 364.28 Million USD | -61.942% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4834.2% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4551.001% |
| NeurAxis, Inc. | 1.91 Million USD | -30742.316% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1415.446% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4324.608% |
| Achilles Therapeutics plc | 19.08 Million USD | -2990.758% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3976.093% |
| 180 Life Sciences Corp. | 5.38 Million USD | -10850.624% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2400.989% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2492.003% |
| Nutriband Inc. | 1.07 Million USD | -54578.155% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1828.012% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3965.419% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -47.015% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1716.688% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4420.873% |
| Palisade Bio, Inc. | 2.73 Million USD | -21438.262% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11130.402% |
| Beam Therapeutics Inc. | 478.38 Million USD | -23.318% |
| Neurogene Inc. | 36.54 Million USD | -1514.088% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -48.243% |
| AEON Biopharma, Inc. | 159.88 Million USD | -268.964% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1138.055% |
| Sesen Bio, Inc. | 30.98 Million USD | -1803.992% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2172.382% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -7660.014% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -201.389% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -207.166% |
| Athira Pharma, Inc. | 30.05 Million USD | -1862.714% |
| Vaccinex, Inc. | 5.94 Million USD | -9828.189% |
| HCW Biologics Inc. | 15.05 Million USD | -3819.315% |
| XOMA Corporation | 145.58 Million USD | -305.229% |
| Nektar Therapeutics | 267.04 Million USD | -120.911% |
| Arvinas, Inc. | 644.6 Million USD | 8.481% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3226.728% |
| Merus N.V. | 102.15 Million USD | -477.511% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -303.097% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -520.199% |
| Rezolute, Inc. | 11.73 Million USD | -4927.552% |
| Clene Inc. | 38.95 Million USD | -1414.552% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -20618.45% |
| BeyondSpring Inc. | 48.26 Million USD | -1122.178% |
| Synlogic, Inc. | 32.89 Million USD | -1693.382% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3937.042% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -36003.611% |
| Peak Bio, Inc. | 20.75 Million USD | -2742.59% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -829.629% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1385.453% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -56.629% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -492.487% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -136229.456% |
| MannKind Corporation | 721.36 Million USD | 18.22% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2541.294% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -28180.585% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -475.039% |
| Gossamer Bio, Inc. | 249.14 Million USD | -136.781% |
| CohBar, Inc. | 1.03 Million USD | -56973.463% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5419.066% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2997.086% |
| Mural Oncology plc | 37.92 Million USD | -1455.402% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -344.776% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -25601.424% |
| Disc Medicine, Inc. | 22.87 Million USD | -2478.942% |
| Champions Oncology, Inc. | 28.03 Million USD | -2004.273% |
| REGENXBIO Inc. | 262.22 Million USD | -124.969% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -17460.917% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4606.662% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4292.119% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2682.047% |
| Vaxart, Inc. | 34.02 Million USD | -1633.822% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2793.351% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1967.627% |
| Cellectis S.A. | 249.57 Million USD | -136.375% |
| Longeveron Inc. | 5.33 Million USD | -10953.644% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1310.682% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 75.473% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -877.228% |
| Revolution Medicines, Inc. | 262.39 Million USD | -124.825% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -27898.719% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -6739.01% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4899.009% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4100.904% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -27325.988% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 88.545% |
| Denali Therapeutics Inc. | 122.96 Million USD | -379.765% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10500.975% |
| Veru Inc. | 32.81 Million USD | -1697.88% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8488.339% |
| Cingulate Inc. | 10.36 Million USD | -5593.859% |
| Passage Bio, Inc. | 39.26 Million USD | -1402.555% |
| Context Therapeutics Inc. | 4.19 Million USD | -13973.786% |
| Exicure, Inc. | 8.54 Million USD | -6800.608% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1899.231% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5525.911% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2576.526% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -261.953% |
| Nuvalent, Inc. | 31.82 Million USD | -1753.794% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9173.304% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -836.075% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3177.406% |
| OmniAb, Inc. | 87.4 Million USD | -574.981% |
| Anew Medical, Inc. | 8.24 Million USD | -7057.818% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1440.734% |
| Lipocine Inc. | 2.63 Million USD | -22317.028% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2145.482% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1367.057% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2114.313% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -584.742% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -10822.662% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -612.936% |
| Ocugen, Inc. | 23.98 Million USD | -2359.797% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1171.216% |
| Q32 Bio Inc. | 233.12 Million USD | -153.051% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6407.092% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1002.637% |
| Equillium, Inc. | 27.95 Million USD | -2010.144% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -185.555% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10384.594% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -9519.046% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -274.975% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -749.644% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -5814.589% |
| Dominari Holdings Inc. | 4.63 Million USD | -12627.789% |
| Edesa Biotech, Inc. | 1.84 Million USD | -31933.077% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1895.241% |
| Bio-Techne Corporation | 744.34 Million USD | 20.744% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -367.833% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -71.265% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1353.932% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1937.273% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -538.732% |
| Nkarta, Inc. | 105.6 Million USD | -458.649% |
| BioCardia, Inc. | 4.59 Million USD | -12752.571% |
| Iterum Therapeutics plc | 32.66 Million USD | -1706.175% |